A practical reference on peptide fragment: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
Reviewed 2025-11-22. Anything still debated is marked as such rather than presented as settled.
Thymosin beta-4 contains 43 amino acids and has a reported molecular mass near 4963 Da. The short fragment most often associated with the TB-500 label, an acetylated chain beginning LKKTETQ, has a reported mass near 889 Da, so the two are easily separated in analytical work. Mass spectrometry and amino acid analysis can confirm which material is present in a given sample. Statements treating TB-500 and thymosin beta-4 as interchangeable are therefore imprecise, even though the two appear together in much of the same literature.
Interest in the compound comes largely from studies of the parent protein, which participates in actin sequestration, cell migration and tissue repair processes. Whether a short fragment reproduces those activities is a separate question that remains open in the published record. Many summaries describe mechanisms by analogy to thymosin beta-4 rather than from direct measurements on the fragment. Claims about activity should be treated as provisional unless a cited study specifies the exact peptide, its purity and the assay used.
Sports authorities classify the peptide as a prohibited substance, and it appears on the World Anti-Doping Agency list under peptide hormones, growth factors, and related substances. Racing jurisdictions for horses and dogs have issued separate restrictions, and several national bodies treat it as a controlled or prescription-only item. As a research chemical it is sold without a therapeutic indication, and labels usually state that the product is not for human or veterinary use. Regulatory treatment therefore varies by country.
Detection in biological matrices generally relies on liquid chromatography coupled with tandem mass spectrometry, because the peptide lacks a convenient ultraviolet chromophore beyond the amide backbone. Immunoassays have been described, but antibodies raised against the fragment can cross-react with the full-length protein or with unrelated peptides, so findings usually require confirmation by a second technique. Sample preparation typically involves protein precipitation followed by solid-phase extraction. Reported detection windows depend on dose, route, matrix, and instrument sensitivity.
Lyophilised material is stable for extended periods when kept dry and cold, and suppliers typically recommend storage well below freezing. Once dissolved, the peptide is handled at refrigeration temperatures and used within a short period, because peptide bonds and the acetylated terminus can be affected by repeated freeze-thaw cycles, proteases, or extreme pH. Bacteriostatic water and saline are both described as solvents, although preservatives can interfere with some analytical workflows. Reconstituted solutions are inspected for particulates before use.
| Property | Value | Notes |
|---|---|---|
| Physical form | Lyophilised powder | Sealed vial; reconstituted before laboratory use |
| Appearance | White to off-white solid | Visual descriptor used on certificates of analysis |
| Solubility class | Water-soluble | Dissolves in water and aqueous buffers |
| Reported mass, fragment | Near 889 Da | Value depends on the stated sequence |
| Reported mass, parent protein | Near 4963 Da | 43-residue thymosin beta-4 |
Thymosin beta-4 is a naturally occurring protein of 43 amino acids found in most mammalian cells, where it binds actin monomers and influences filament dynamics. It was first isolated from thymus tissue in the early 1980s, and its actin-binding activity was later mapped to a short region near the N-terminus. The synthetic fragment sold as TB-500 was designed to reproduce that region rather than the full protein. Whether a short fragment reproduces the behavior of the intact molecule remains an open question, since the parent protein carries additional structural elements outside the binding region.
Published research on the intact protein is substantial, covering actin regulation, cell migration, and wound models. Research using the heptapeptide fragment specifically is far smaller, and much of the circulating material originates in supplier documentation rather than peer-reviewed reports. Where fragment studies do exist, they often employ different sequences, chain lengths, or terminal modifications, which complicates direct comparison across papers. Readers encountering claims about TB-500 should therefore separate evidence about thymosin beta-4 from evidence about the fragment itself.
TB-500 is a catalogue name applied to a synthetic peptide related to thymosin beta-4, an actin-binding protein found in most mammalian cells. Suppliers do not use the label consistently: some describe it as the full 43-residue protein, others as a short fragment from the actin-binding region, and others as a related tetrapeptide. Because the name is commercial rather than chemical, two products sold under it may not contain the same molecule. This naming ambiguity is the first point to check in any description of the material.
The most frequently cited identity is a seven-residue fragment with the sequence LKKTETQ, taken from the actin-binding domain of the parent protein. A separate molecule, N-acetyl-seryl-aspartyl-lysyl-proline, often shortened to Ac-SDKP, derives from the same protein's N-terminal region and appears in overlapping literature. Reported molecular masses therefore differ between sources, and a mass value on its own does not establish which fragment is present. Confirmation requires a defined sequence rather than a single number.
227Ac is highly radioactive and was therefore studied for use as an active element of radioisotope thermoelectric generators, for example in spacecraft. The oxide of 227Ac pressed with beryllium is also an efficient neutron source with the activity exceeding that of the standard americium-beryllium and radium-beryllium pairs. In these applications, 227Ac (a weak beta source emitting few alphas of its own) is essentially a progenitor which generates alpha-emitting isotopes upon its decay. Beryllium captures alpha particles and emits neutrons owing to its large cross-section for the (α,n) nuclear reaction:
On 10 November 1952 Thomas's last collection Collected Poems, 1934–1952, was published by Dent; he was 38. It won the Foyle poetry prize. Reviewing the volume, critic Philip Toynbee declared that "Thomas is the greatest living poet in the English language". The winter of 1952/3 brought much personal tragedy: Thomas's father died from pneumonia just before Christmas 1952; and in the Spring of 1953 his sister died from liver cancer, one of his patrons overdosed, three friends died at young ages and Caitlin had an abortion.
Ubayd Allah's father prepared him to succeed him as governor, and indeed, after Ziyad's death in 672/673, Ubayd Allah became governor of Khurasan. A year or two later, he was also appointed to the governorship of Basra. According to historian Hugh N. Kennedy, Ubayd Allah was "more hasty and given to the use of force than his father, but a man whose devotion to the Umayyad cause could not have been doubted". In 674 he crossed the Amu Darya and defeated the forces of the ruler of Bukhara in the first known invasion of the city by Muslim Arabs. After he was appointed governor of Basra soon afterwards, he also took several thousand Bukharan captives with him as slaves. Out of those slaves the Bukhariya military unit was formed. From at least 674 and 675, Ubayd Allah had coins struck in his name in Khurasan and Basra, respectively. They were based on Sasanian coinage and written in Pahlavi script. The mints were located in Basra, Darabjird, Maysan, Narmashir, Jayy and, to a lesser extent, Kufa. The latter was attached to Ubayd Allah's governorship in 679/680, giving him full control of Iraq.
=== Farnesoid X-receptor agonist === A new novel treatment option is the farnesoid X receptor is responsible for regulating bile acid homeostasis. An agonist of this nuclear hormone receptor is seen as a possible treatment as it can downregulate bile acid synthesis and reabsorption. Further the farnesoid X receptor is partly responsible for lipid and glucose homeostasis, as well as pathogen recognition. An agonist for the farnesoid X receptor can therefore lead to an anti-cholestatic environment to minimize the effect of toxic bile acids on the liver. A candidate agonist for the farnesoid X receptor is obeticholic acid with experiments showing it has very strong affinity. A worry though is despite benefits in the biochemical pathways, pruritus was more intense and prevalent than the placebo. A titration strategy may help to mitigate pruritus, but FDA approval for obeticholic acid is currently unlikely. In fact, in February 2018, the FDA gave a black box warning for OCA. A recent study did find that if the drug is given with UDCA, the incidence for cirrhosis and liver transplants decreases. Another target that is being looked into is the all-trans retinoic acid (ATRA), an activator for the retinoid X receptor. In vitro and animal studies found ATRA had lowered the amount of bile acid and decreased hepatic inflammation.
When Napoleon invaded Russia in 1812, Muscovites were evacuated. The Moscow fire was principally the effect of Russian sabotage. Napoleon's Grande Armée (lit. 'Great Army') was forced to retreat and was nearly annihilated by the devastating Russian winter. In 1813, following the city's destruction during the French occupation, the Commission for the Construction of the City of Moscow was established. This commission launched a major program of rebuilding, including a partial replanning of the city center. Among many buildings constructed or reconstructed during this time were the Grand Kremlin Palace and the Kremlin Armoury, the Moscow University, the Moscow Manege (Riding School), and the Bolshoi Theatre. Arbat Street had been in existence since the 15th century or earlier, but this street developed into a prestigious area during the 18th century. The street was destroyed in the fire of 1812 and was rebuilt completely in the early 19th century. Moscow State University was established in 1755. Its main building was reconstructed after the 1812 fire by architect Domenico Giliardi. The Moskovskiye Vedomosti newspaper appeared in 1756, originally at weekly intervals, and from 1859 onward as a daily newspaper. During the 1830s, general Alexander Bashilov planned the first regular grid of city streets north of Petrovsky Palace. Khodynka field, south of the highway, was used for military training. Smolensky Rail station (the forerunner of the Belorussky Rail Terminal) was inaugurated in 1870.
Sources: en.wikipedia.org
== Clinical significance == In addition to their roles in cancer development and chemotherapeutic drug resistance, GSTs are implicated in a variety of diseases by virtue of their involvement with GSH. Although the evidence is minimal for the influence of GST polymorphisms of the alpha, mu, pi, and theta classes on susceptibility to various types of cancer, numerous studies have implicated such genotypic variations in asthma, atherosclerosis, allergies, and other inflammatory diseases. Because diabetes is a disease that involves oxidative damage, and GSH metabolism is dysfunctional in diabetic patients, GSTs may represent a potential target for diabetic drug treatment. In addition, insulin administration is known to result in increased GST gene expression through the PI3K/AKT/mTOR pathway and reduced intracellular oxidative stress, while glucagon decreases such gene expression. Omega-class GST (GSTO) genes, in particular, are associated with neurological diseases such as Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis; again, oxidative stress is believed to be the culprit, with decreased GSTO gene expression resulting in a lowered age of onset for the diseases.
=== Animal-derived === Some drugs used in modern medicine have been discovered in animals or are based on compounds found in animals. For example, the anticoagulant drugs, hirudin and its synthetic congener, bivalirudin, are based on saliva chemistry of the leech, Hirudo medicinalis. Used to treat type 2 diabetes, exenatide was developed from saliva compounds of the Gila monster, a venomous lizard.
=== Microelectronics === The accurate and damage-free surface ion milling provides makes it perfect for the precise fabrication of semiconductors. Using ion milling for microelectronics can create well-defined features and patterns on semiconductor wafers.
Because dextromethorphan (DXM) acts predominantly as the parent compound rather than through dextrorphan in Auvelity, the contribution of the active metabolite can largely be disregarded when analyzing Auvelity's pharmacological effects. Dextrorphan primarily provides NMDA channel blockade. However, DXM itself exhibits its strongest activity as a serotonin transporter (SERT) inhibitor and σ1 receptor agonist, while its NMDA antagonism is actually quite weak. In Auvelity, the conversion of DXM to dextrorphan by the CYP2D6 enzyme is substantially inhibited by bupropion, resulting in extremely high plasma concentrations of the parent DXM. Consequently, Auvelity's NMDA receptor antagonism is clinically quite limited, whereas σ1 receptor agonism and SERT inhibition become the dominant pharmacological actions. Based on pharmacokinetic data, it can be inferred that DXM in Auvelity may achieve approximately 60–85% whole-brain SERT occupancy, a level comparable to that of most SSRIs (selective serotonin reuptake inhibitors). In addition, σ1 receptor agonism, which was previously investigated as a target for antidepressant development, likely contributes to Auvelity's therapeutic efficacy. Bupropion produces relatively strong inhibition of the norepinephrine transporter (NET) and achieves approximately 14–28% dopamine transporter (DAT) occupancy, making it an NDRI (norepinephrine-dopamine reuptake inhibitor). Bupropion also antagonizes nicotinic acetylcholine receptors, acts as a weak positive allosteric modulator of the σ1 receptor, and inhibits 5-HT3 receptors.
Sources: en.wikipedia.org
=== Computing === C4 (conference), a Macintosh software developers conference C4 Engine, a next-generation 3D game engine C4 model, a graphical notation technique for diagramming software architecture Cx4 chip, an add-on microprocessor chip employed by certain Super NES game cartridges (often incorrectly referred to as the C4 chip) Controlled collapse chip connection or flip chip, a method for interconnecting semiconductor devices VIA C4, a planned design of central processing unit for a personal computer
== Conformational change and inhibitory mechanism == Inhibitory serpins do not inhibit their target proteases by the typical competitive (lock-and-key) mechanism used by most small protease inhibitors (e.g. Kunitz-type inhibitors). Instead, serpins use an unusual conformational change, which disrupts the structure of the protease and prevents it from completing catalysis. The conformational change involves the RCL moving to the opposite end of the protein and inserting into β-sheet A, forming an extra antiparallel β-strand. This converts the serpin from a stressed state, to a lower-energy relaxed state (S to R transition). Serine and cysteine proteases catalyse peptide bond cleavage by a two-step process. Initially, the catalytic residue of the active site triad performs a nucleophilic attack on the peptide bond of the substrate. This releases the new N-terminus and forms a covalent ester-bond between the enzyme and the substrate. This covalent complex between enzyme and substrate is called an acyl-enzyme intermediate. For standard substrates, the ester bond is hydrolysed and the new C-terminus is released to complete catalysis. However, when a serpin is cleaved by a protease, it rapidly undergoes the S to R transition before the acyl-enzyme intermediate is hydrolysed. The efficiency of inhibition depends on fact that the relative kinetic rate of the conformational change is several orders of magnitude faster than hydrolysis by the protease.
Bush was criticized internationally and targeted by the global anti-war and anti-globalization movements for his administration's foreign policy. Views of him within the international community – even in France, a close ally of the United States – were more negative than those of most previous American presidents. Bush was described as having especially close personal relationships with Tony Blair of the United Kingdom and Vicente Fox of Mexico, although formal relations were sometimes strained. Other leaders, such as Hamid Karzai of Afghanistan, Yoweri Museveni of Uganda, José Luis Rodríguez Zapatero of Spain, and Hugo Chávez of Venezuela, openly criticized the president. Later in Bush's presidency, tensions arose between him and Vladimir Putin, which led to a cooling of their relationship. In 2006, most respondents in 18 of 21 countries surveyed around the world were found to hold an unfavorable opinion of Bush. Respondents indicated that they judged his administration as negative for world security. In 2007, the Pew Global Attitudes Project reported that during the Bush presidency, attitudes towards the United States, and towards Americans, became less favorable around the world. The Pew Research Center's 2007 Global Attitudes poll found that in only nine countries of 47 did most respondents express "a lot of confidence" or "some confidence" in Bush: Ethiopia, Ghana, India, Israel, Ivory Coast, Kenya, Mali, Nigeria, and Uganda.
Sources: en.wikipedia.org
No. TB-500 is a trade-style label used for a synthetic peptide described as a fragment of thymosin beta-4, while thymosin beta-4 is the full 43-residue protein. The two differ in size and are not interchangeable terms in analytical work.
Naming for research peptides is not standardised, and suppliers sometimes apply the same label to different chain lengths. Certificates of analysis and mass data are the practical way to determine what a given lot contains.
The fragment commonly cited under this label is reported near 889 Da, and the parent protein near 4963 Da. Reported values shift with the exact sequence and with residual counter-ions or water in the sample.
The most common approach is liquid chromatography with tandem mass spectrometry after extraction from blood or urine. Immunoassays exist but are generally treated as screening tools because of cross-reactivity.